SCHEMBL5083275

SCHEMBL5083275

Cc1cc2cccc(O)c2cc1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 5/20 0.56
HSD17B2 P37059 5/20 0.56
CYP1A2 P05177 2/20 0.50
PLAU P00749 1/20 0.50
GRIN2D O15399 1/20 0.50
GRIN2A Q12879 1/20 0.50
GRIN2B Q13224 1/20 0.50
GRIN2C Q14957 1/20 0.50
CTDSP1 Q9GZU7 1/20 0.50
ESR1 P03372 2/20 0.47
ESR2 Q92731 2/20 0.47
TRPA1 O75762 2/20 0.44
ATM Q13315 1/20 0.44
TLR8 Q9NR97 1/20 0.42
IDO1 P14902 1/20 0.42
TDO2 P48775 1/20 0.42
TRPM4 Q8TD43 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
DNMT1 P26358 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2608798 0.89 HSD17B1 (0.59) HSD17B1HSD17B2CYP1A2PLAUGRIN2D
SCHEMBL10054046 0.89 HSD17B1 (0.59) HSD17B1HSD17B2CYP1A2PLAUGRIN2D
SCHEMBL19425721 0.84 HSD17B1 (0.55) HSD17B1HSD17B2CYP1A2PLAUGRIN2D
SCHEMBL15631716 0.84 HSD17B1 (0.50) HSD17B1HSD17B2CYP1A2PLAUGRIN2D
SCHEMBL19615843 0.84 HSD17B1 (0.50) HSD17B1HSD17B2CYP1A2PLAUGRIN2D
SCHEMBL2115683 0.83 CYP1A2 (0.62) HSD17B1HSD17B2CYP1A2PLAUGRIN2D
SCHEMBL29857010 0.83 CYP1A2 (0.62) HSD17B1HSD17B2CYP1A2PLAUGRIN2D
SCHEMBL7047251 0.81 HSD17B1 (0.47) HSD17B1HSD17B2CYP1A2PLAUGRIN2D
SCHEMBL7046826 0.81 HSD17B1 (0.47) HSD17B1HSD17B2CYP1A2PLAUGRIN2D
SCHEMBL7048770 0.81 HSD17B1 (0.47) HSD17B1HSD17B2CYP1A2PLAUGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118932351-A Electrochemical tandem preparation and application of antibacterial compound 2-amino quinone 温州医科大学附属口腔医院 2024-11-12 CN claimed
CN-118932351-A Electrochemical tandem preparation and application of antibacterial compound 2-amino quinone 温州医科大学附属口腔医院 2024-11-12 CN disclosed
EP-4153555-B1 PHOTOOXIDATION OF PHENOLIC COMPOUNDS DSM IP ASSETS BV (NL) 2024-01-31 EP disclosed
EP-4153555-A1 PHOTOOXIDATION OF PHENOLIC COMPOUNDS DSM IP Assets B.V. (NL) 2023-03-29 EP disclosed
CN-115667201-A Photooxidation of phenolic compounds 帝斯曼知识产权资产管理有限公司 2023-01-31 CN disclosed
US-20120205822-A1 RESIN COMPOSITION FOR ENCAPSULATING SEMICONDUCTOR AND SEMICONDUCTOR DEVICE USING THE RESIN COMPOSITION SUMITOMO BAKELITE CO., LTD. (JP) 2012-08-16 US disclosed
US-20080314294-A1 Petroleum Asphalts Modified by Liquefied Biomass Additives WHITE DONALD H 2008-12-25 US disclosed
CN-1211336-C High-quality bisphenol A and process for producing the same MITSUI CHEMICALS INC (JP) 2005-07-20 CN disclosed
US-20030212168-A1 Petroleum asphalts modified by liquefied biomass additives WHITE DONALD H (US) 2003-11-13 US disclosed
US-20030028055-A1 High quality bisphenol a and preparation process thereof MITSUI CHEMICALS, INC. (JP) 2003-02-06 US disclosed
EP-1149816-A1 HIGH-QUALITY BISPHENOL A AND PROCESS FOR PRODUCING THE SAME Mitsui Chemicals, Inc. (JP) 2001-10-31 EP disclosed
WO-2001059008-A1 PETROLEUM ASPHALTS MODIFIED BY LIQUEFIED BIOMASS ADDITIVES WASTE TECHNOLOGY TRANSFER, INC. (US) 2001-08-16 WO disclosed
US-5916826-A COAL PELLET MIXTURE COMPRISES A BIO-BINDER BASE OBTAINED BY DIRECT LIQUEFACTION OF CELLULOSE BIO-MATERIAL AND COAL FINES WASTE TECHNOLOGY TRANSFER, INC. (US) 1999-06-29 US disclosed
WO-1999029812-A1 COAL BINDER PRODUCED BY LIQUEFACTION OF BIOMASS WASTE TECHNOLOGY TRANSFER, INC. (US) 1999-06-17 WO disclosed
US-4061642-A AZO DYE INTERMEDIATES CASSELLA FARBWERKE MAINKUR AG (DT) 1977-12-06 US disclosed
US-3980659-A INSECTICIDES, INTERMEDIATES FOR AZO DYES CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) 1976-09-14 US disclosed
US-3956294-A AZO DYES, PESTICIDES, ANALEPTICS, ANALGESICS, DIURETICS CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) 1976-05-11 US disclosed
US-3954782-A 2,6-Hydrazino-3-pyridine carboxyamides CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) 1976-05-04 US disclosed
US-3947463-A Certain 2-amino-nicotinonitrile derivatives CASSELLA FARBWERKE MAINKUR AG (DT) 1976-03-30 US disclosed
US-3946024-A INTERMEDIATES FOR AZO DYES CASSELLA FARBWERKE MAINKUR AG (DT) 1976-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030028055-A1 High quality bisphenol a and preparation process thereof TET2, PCBP1, PAH HSD17B1 1965/4885HSD17B2 1480/4885CYP1A2 307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.